Defiance Daily Target 2X Long HIMS ETF (HIMZ) seeks to provide 200% of the daily performance of Hims & Hers Health Inc. stock through leveraged exposure. This single-stock leveraged ETF amplifies the daily movements of the telehealth company that provides direct-to-consumer healthcare products and services.
How It Works
HIMZ uses derivatives including swaps and futures contracts to achieve twice the daily return of HIMS stock, resetting its leverage ratio each trading day. The fund employs an active management approach to maintain precise 2x exposure through continuous rebalancing of derivative positions. Daily reset mechanics mean the fund's performance over periods longer than one day will differ significantly from 2x the underlying stock's cumulative return due to compounding effects.
Key Features
- Only ETF providing 2x leveraged exposure to Hims & Hers Health, targeting the growing telehealth and direct-to-consumer healthcare market
- Daily rebalancing ensures precise 2x exposure each trading day, making it suitable for short-term directional bets on HIMS stock
- Recently launched in March 2025, offering traders a new tool for amplified exposure to digital healthcare innovation trends
Risks
- This ETF can lose value rapidly due to daily compounding effects—if HIMS drops 10% then rises 10%, the fund does not return to break-even
- Single-stock concentration means 100% exposure to Hims & Hers business risks including regulatory changes, competition, and execution challenges that could cause permanent losses
- Leveraged structure amplifies all volatility, potentially causing 40-60% daily swings during periods of high market stress or company-specific news events
Who Should Own This
Designed exclusively for active traders with high risk tolerance seeking short-term (hours to days) amplified exposure to HIMS stock movements. Requires constant monitoring and should represent less than 5% of total portfolio. Unsuitable for buy-and-hold investors due to daily reset mechanics that erode returns over time.